文献速递系统性红斑狼疮

系统性红斑狼疮中浆母细胞分化通过谷氨酰胺代谢增强线粒体功能

An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

研究评估系统性红斑狼疮(SLE)患者B细胞代谢异常及其与浆母细胞分化的关系。发现SLE患者B细胞线粒体膜超极化标志物DiOc6表达升高,与浆母细胞比例及SLEDAI相关;谷氨酰胺代谢通过增强线粒体功能促进浆母细胞分化,可能成为SLE潜在治疗靶点。

要点

  • SLE患者B细胞DiOc6表达高于健康对照,且与浆母细胞比例及SLEDAI相关。
  • CpG和IFN-α刺激增强糖酵解、OXPHOS、DiOc6表达及浆母细胞分化。
  • 谷氨酰胺缺乏抑制糖酵解、OXPHOS及浆母细胞分化,而葡萄糖缺乏无此变化。

核心结论

  • B细胞线粒体功能障碍与SLE浆母细胞分化和疾病活动度相关。
  • 谷氨酰胺代谢介导的线粒体功能增强对浆母细胞分化重要,可能是SLE潜在治疗靶点。

研究设计与样本

  • 研究采用流式细胞术检测健康对照和SLE患者外周血B细胞代谢标志物表达。
  • 体外分离健康对照和SLE患者外周B细胞,研究其分化相关的代谢调控机制。

主要发现

  • SLE患者B细胞DiOc6表达水平高于健康对照,且与CD19+细胞中浆母细胞百分比及SLEDAI相关。
  • CpG和IFN-α刺激CD19+细胞增强糖酵解、OXPHOS、DiOc6表达及体外浆母细胞分化。
  • 无谷氨酰胺时糖酵解和OXPHOS均降低,浆母细胞分化受抑制;无葡萄糖时无变化。
  • 谷氨酰胺酶抑制剂BPTES降低DiOc6表达、OXPHOS、ROS产生、ATP产生及浆母细胞分化,不影响糖酵解。
  • 二甲双胍抑制CpG和IFN-α诱导的谷氨酰胺摄取、线粒体功能并抑制浆母细胞分化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the dysfunction of B-cell metabolism and its involvement in SLE pathology. METHODS: We assessed the expression of metabolic markers of B cells in the peripheral blood of healthy controls (HCs) and SLE patients by using flow cytometry. In vitro, peripheral B cells were isolated from HCs and SLE patients to investigate the metabolic regulation mechanisms involved in their differentiation. RESULTS: The expression level of DiOc6 (mitochondrial membrane hyperpolarization) was higher in B cells from SLE patients than in HCs, and correlated to the percentage of plasmablasts in CD19+ cells and with SLEDAI, a disease activity score. Stimulation of CD19+ cells with the Toll-like receptor 9 (TLR9) ligand CpG and IFN-α enhanced glycolysis, oxidative phosphorylation (OXPHOS), DiOc6 expression, and plasmablast differentiation in vitro. In the absence of glutamine, both glycolysis and OXPHOS were reduced, and plasmablast differentiation was suppressed, whereas there was no change in the absence of glucose. As glutamine is an important nutrient for protein synthesis, we further investigated the effect of the glutaminase inhibitor BPTES, which inhibits glutamine degradation, on metabolic regulation. BPTES reduced DiOc6 expression, OXPHOS, reactive oxygen species (ROS) production, adenosine triphosphate (ATP) production, plasmablast differentiation without affecting glycolysis. Metformin inhibited CpG- and IFN-α-induced glutamine uptake, mitochondrial functions and suppressed plasmablast differentiation. CONCLUSIONS: Mitochondrial dysfunction in B cells is associated with plasmablast differentiation and disease activity in SLE. Enhanced mitochondrial functions mediated by glutamine metabolism are important for plasmablast differentiation, which may be a potential therapeutic target for SLE.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Sumikawa MH, Iwata S, Zhang M, et al. An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus. Rheumatology (Oxford). 2022. PMID: 34730825. doi:10.1093/rheumatology/keab824

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。